Delivery of optimized inpatient anticoagulation therapy: Consensus statement from the anticoagulation forum;Terapia de anticoagulación optimizada en el paciente hospitalizado: Declaración de consenso del Foro de Anticoagulación

Annals of Pharmacotherapy

Volumn 47, Issue 5, 2013, Pages 714-724

  Nutescu, Edith A ^a,b   Wittkowsky, Ann K ^c,d   Burnett, Allison ^e   Merli, Geno J ^f   Ansell, Jack E ^g   Garcia, David A ^e,h  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g LENOX HILL HOSPITAL   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTHROMBIN; VITAMIN K GROUP; WARFARIN;

ALGORITHM; ANTICOAGULANT THERAPY; ARTICLE; CONSENSUS; HEALTH CARE DELIVERY; HOSPITAL PATIENT; HUMAN; INTEGRATION; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PATIENT SAFETY; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RISK FACTOR; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

EID: 84877090027     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R634     Document Type: Article

References (40)

1. Garcia DA, Schwartz MJ. Warfarin therapy: tips and tools for better control. J Fam Pract 2011;60:70-5.
2. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007;167:1414-9.
3. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.
4. QuarterWatch. Monitoring FDA MedWatch Reports. Anticoagulants the leading reported drug risk in 2011. www.ismp.org/QuarterWatch/pdfs/ 2011Q4.pdf (accessed 2013 Jan 7).
5. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12. doi: 10.1056/NEJMsa1103053
6. Fanikos J, Stapinski C, Koo S, Kucher N, Tsilimingras K, Goldhaber SZ. Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol 2004;94:532-5.
7. Bond CA, Raehl CL. Adverse drug reactions in United States hospitals. Pharmacotherapy 2006;26:601-8.
8. The Joint Commission. Sentinel event alert. Preventing errors relating to commonly used anticoagulants. www.jointcommission.org/assets/1/18/ SEA_41.PDF (accessed 2013 Jan 7).
9. The Joint Commission. National patient safety goals NPSG 03.01.05. www. jointcommission.org/assets/1/18/NPSG_Chapter_Jan2013_AHC.pdf (accessed 2013 Jan 7).
10. Institute for Safe Medication Practices. Improving medication safety with anticoagulant therapy. www.ismp.org/tools/anticoagulantTherapy.asp (accessed 2013 Jan 7).
11. Centers for Medicare and Medicaid Services. Hospital-acquired conditions. www.cms.gov/HospitalAcqCond/06_Hospital-Acquired_Conditions.asp (accessed 2013 Jan 7).
12. Garcia DA, Witt DM, Hylek E, et al. Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 2008;42:979-88. doi: 10.1345/aph.1L098.
13. Institute of Medicine. To err is human: building a safer health system. 1999. www.iom.edu/~/media/Files/Report%20Files/1999/To-Err-is-Human/ To%20Err%20is%20Human%201999%20%20report%20brief.pdf (accessed 2013 Jan 7).
14. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE prevention study group. JAMA 1995;274:35-43.
15. Institute for Safe Medication Practices. Organizations release new tools for reducing medication errors. 2012. www.ismp.org/Tools/pathways.asp (accessed 2013 Apr 3).
16. National Quality Forum. Safe practices for better healthcare. www.quality forum.org/Publications/2009/03/Safe_Practices_for_Better_Healthcare %e2%80%932009_Update.aspx (accessed 2013 Jan 7).
17. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weightbased heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993;119:874-81.
18. Elliott CG, Hiltunen SJ, Suchyta M, et al. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med 1994;154:999-1004.
19. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7.
20. Hollingsworth JA, Rowe BH, Brisebois FJ, Thompson PR, Fabris LM. The successful application of a heparin nomogram in a community hospital. Arch Intern Med. 1995;155:2095-100.
21. Phillips WS, Smith J, Greaves M, Preston FE, Channer KS. An evaluation and improvement program for inpatient anticoagulant control. Thromb Haemost 1997;77:283-8.
22. Brown G, Dodek P. An evaluation of empiric vs nomogram-based dosing of heparin in an intensive care unit. Crit Care Med 1997;25:1534-8.
23. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999;6:313-21.
24. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med 2010;362:1698-707. doi: 10.1056/NEJMsa0907115
25. Garcia DA, Highfill J, Finnerty K, et al. A prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients. Blood Coagul Fibrinolysis 2009;20:541-5. doi: 10.1097/MBC.0b013e32832d6cfc
26. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352: 969-77.
27. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009;119:2196-201. doi: 10.1161/CIRCULATIONAHA.108.841197
28. Sobieraj DM. Development and implementation of a program to assess medical patients' need for venous thromboembolism prophylaxis. Am J Health Syst Pharm 2008;65:1755-60. doi: 10.2146/ajhp070598
29. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
30. Dager WE, Gulseth MP. Implementing anticoagulation management by pharmacists in the inpatient setting. Am J Health Syst Pharm 2007;64: 1071-9.
31. Dager WE, Branch JM, King JH, et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 2000;34:567-72. doi: 10.1345/aph.18192
32. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy 2004;24: 953-63.
33. Donovan JL, Drake JA, Whittaker P, Tran MT. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis 2006;22:23-30.
34. Locke C, Ravnan SL, Patel R, Uchizono JA. Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service. Pharmacotherapy 2005;25: 685-9.
35. Schillig J, Kaatz S, Hudson M, Krol GD, Szandzik EG, Kalus JS. Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med 2011;6:322-8. doi: 10.1002/jhm.910
36. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 1992;49:387-94.
37. Rivey MP, Peterson JP. Pharmacy-managed, weight-based heparin protocol. Am J Hosp Pharm 1993;50:279-84.
38. Tully MP, Ashcroft DM, Dornan T, Lewis PJ, Taylor D, Wass V. The causes of and factors associated with prescribing errors in hospital inpatients: a systematic review. Drug Saf 2009;32:819-836. doi: 10.2165/11316560-000000000-00000
39. National Certification Board for Anticoagulation Providers. https://www. ncbap.org/aboutcacpexam.aspx (accessed 2013 Apr 3).
40. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360: 1418-28. doi: 10.1056/NEJMsa0803563